Company Profile
Our company is located in Suzhou Biobay, We have established our own chemosynthesis laboratory with the area of 200 square meters. What’s more, we have built a factory which covering the area of over 1000 square meters in Jiangxi. It has passed GMP. The factory which is equipped with 50L-16000L reaction stills and the corollary equipments can meet the needs of customization or manufacture from pilot plant to large industrial scale.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
3-Azetidinethiol, 1-(4,5-dihydro-2-thiazolyl)-, monohydrochloride |
3-Azetidinethiol, 1-(4,5-dihydro-2-thiazolyl)-, monohydrochloride;3-Mercapto-1-(1,3-thiazolin-2-yl)azetidine hydrochloride;1-(4,5-Dihydro-2-thiazolyl)-3-azetidinethiol hydrochloride;2-(3-Mercaptoazetidin-1-yl)-2-thiazoline hydrochloride;Side Chain of TebipeneM;TebipeneM Side Chain;TebipenaM Side Chain;1-(4,5-Dihydrothiazol-2-yl)azetidine-3-thiol hydrochloride |
179337-57-6 | Inquiry | |
abiraterone acetate |
Androsta-5,16-dien-3-ol,17-(3-pyridinyl)-,acetate (ester),(3β)-;CB 7630;Abiraterone acetate;Zytiga;(3β)-17-(3-Pyridinyl)androsta-5,16-dien-3-yl acetate;1643848-36-5 |
154229-18-2 | Inquiry | |
AvibactaM |
Sulfuric acid,mono[(1R,2S,5R)-2-(aminocarbonyl)-7-oxo-1,6-diazabicyclo[3.2.1]oct-6-yl] ester;Avibactam |
1192500-31-4 | Inquiry | |
Brexpiprazole |
Brexpiprazole impurity a;CS-1678;OPC 34712; OPC34712; OPC-34712;Brexpiprazole(OPC34712);7-{4-[4-(1-Benzothiophen-4-yl)piperazin-1-yl]butoxy}quinolin-2(1H)-one;Brexpiprazole;OPC-34712;7-[4-(4-benzo[b]thien-4-yl-1-piperazinyl)butoxy]- 2(1H)-Quinolinone |
913611-97-9 | Inquiry | |
Butanediamide,N4-[(1S)-2,2-dimethyl-1-[(methylamino)carbonyl]propyl]-N1,2-dihydroxy-3-(2-methylpropyl)-,(2S,3R)- |
Butanediamide,N4-[(1S)-2,2-dimethyl-1-[(methylamino)carbonyl]propyl]-N1,2-dihydroxy-3-(2-methylpropyl)-,(2S,3R)-;Butanediamide,N4-[2,2-dimethyl-1-[(methylamino)carbonyl]propyl]-N1,2-dihydroxy-3-(2-methylpropyl)-,[2S-[N4(R*),2R*,3S*]]-;(2S,3R)-N4-[(1S)-2,2-Dimethyl-1-[(methylamino)carbonyl]propyl]-N1,2-dihydroxy-3-(2-methylpropyl)butanediamide;BB 2516;Marimastat;GI 5712;TA 2516;KB-R 8898 |
154039-60-8 | Inquiry | |
Cabazitaxel |
Benzenepropanoic acid,β-[[(1,1-dimethylethoxy)carbonyl]amino]-α-hydroxy-,(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4,6-dimethoxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester,(αR,βS)-;Benzenepropanoic acid,β-[[(1,1-dimethylethoxy)carbonyl]amino]-α-hydroxy-,12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4,6-dimethoxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester,[2aR-[2aα,4β,4aβ,6β,9α(αR*,βS*),11α,12α,12aα,12bα]]-;TXD 258;Cabazitaxel;XRP 6258;Jevtana;DEP cabazitaxel;890654-44-1 |
183133-96-2 | Inquiry | |
Canagliflozin |
D-Glucitol,1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-,(1S)-;(1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol;TA 7284;JNJ 28431754;Canagliflozin;JNJ 28431754AAA;JNJ 24831754ZAE;Invokana;1-(β-D-Glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene;(1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol;2169850-08-0 |
842133-18-0 | Inquiry | |
Carbamic acid,N-[4,6-diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]-N-methyl-,methyl ester |
Carbamic acid,N-[4,6-diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]-N-methyl-,methyl ester;Carbamic acid,[4,6-diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]methyl-,methyl ester;Riociguat;BAY 632521;BAY 63-2521;Methyl [4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl]methylcarbamate;Adempas;Methyl N-[4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]-N-(methyl)carbamate;911138-23-3 |
625115-55-1 | Inquiry | |
Carfilzomib |
Carfilzomib;N-{(2S)-2-[(Morpholin-4-ylacetyl)aMino]-4-phenylbutanoyl}-L-leucyl-N-{(2S)-4-Methyl-1-[(2R)-2-Methyloxiran-2-yl]-1-oxopentan-2-yl}-L-phenylalaninaMide;CarfilzoMib salt;CarfilzoMib/PR 171;PR-171 (CarfilzoMib);(alphaS)-alpha-[(4-Morpholinylacetyl)amino]benzenebutanoyl-L-leucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyloxiranyl]carbonyl]butyl]-L-phenylalaninamide;CarfilzoMib, Free Base, >99%;(S)-4-Methyl-N-((S)-1-((S)-4-Methyl-1-((R)-2- Methyloxiran-2-yl)-1 -oxopentan-2-ylaMino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-MorpholinoacetaMido)-4-phenylbutanaMido)pentanaMide |
868540-17-4 | Inquiry | |
Eltrombopag Olamine |
[1,1′-Biphenyl]-3-carboxylic acid,3′-[(2Z)-2-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl]-2′-hydroxy-,compd. with 2-aminoethanol (1:2);[1,1′-Biphenyl]-3-carboxylic acid,3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-,compd. with 2-aminoethanol (1:2);SB 497115GR;Eltrombopag olamine;Promacta;Eltrombopag diethanolamine salt;Revolade |
496775-62-3 | Inquiry | |
ivacaftor intermediate Ⅰ |
Phenol,5-amino-2,4-bis(1,1-dimethylethyl)-;5-Amino-2,4-bis(1,1-dimethylethyl)phenol;5-Amino-2,4-di-tert-butylphenol |
873055-58-4 | Inquiry | |
ivacaftor intermediate Ⅱ |
3-Quinolinecarboxylic acid,1,4-dihydro-4-oxo-;1,4-Dihydro-4-oxo-3-quinolinecarboxylic acid;4-Quinolone-3-carboxylic acid;4-Oxo-1,4-dihydroquinoline-3-carboxylic acid |
13721-01-2 | Inquiry | |
ivacaftor intermediate Ⅲ |
2,4-di-tert-butyl-5-(4-oxo-1,4-dihydroquinoline-3-carboxamido)phenyl methyl carbonate;N-[5-(Methoxycarbonyloxy)-2,4-di(tert-butyl)phenyl]-4-oxo-1H-quinoline-3-carboxamide;SCHEMBL6730386;ZINC202644360;CS-15231;CS-0006688;[2,4-ditert-butyl-5-[(4-oxo-1H-quinoline-3-carbonyl)amino]phenyl] methyl carbonate |
1246213-45-5 | Inquiry | |
L-Threoninamide,N-acetyl-N-methyl-L-isoleucyl-L-isoleucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyl-2-oxiranyl]carbonyl]butyl]- |
L-Threoninamide,N-acetyl-N-methyl-L-isoleucyl-L-isoleucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyl-2-oxiranyl]carbonyl]butyl]-;L-Threoninamide,N-acetyl-N-methyl-L-isoleucyl-L-isoleucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyloxiranyl]carbonyl]butyl]-;N-Acetyl-N-methyl-L-isoleucyl-L-isoleucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyl-2-oxiranyl]carbonyl]butyl]-L-threoninamide;BU 4061T;Epoxomicin |
134381-21-8 | Inquiry | |
Lesinurad |
Acetic acid,2-[[5-bromo-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]-;Acetic acid,[[5-bromo-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]-;2-[[5-Bromo-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]acetic acid;Lesinurad;RDEA 594;2-[[5-Bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl]thio]acetic acid;Lesinida;Zurampic;READ 594;2-[[5-Bromo-4-(4-cyclopropylnaphthalen-1-yl)-1,2,4-triazol-3-yl]sulfanyl]acetic acid |
878672-00-5 | Inquiry | |
Minodronic Acid |
155648-60-5 | Inquiry | ||
Nintedanib; Intedanib;Vargatef |
1H-Indole-6-carboxylic acid,2,3-dihydro-3-[[[4-[methyl[2-(4-methyl-1-piperazinyl)acetyl]amino]phenyl]amino]phenylmethylene]-2-oxo-,methyl ester,(3Z)-;1H-Indole-6-carboxylic acid,2,3-dihydro-3-[[[4-[methyl[(4-methyl-1-piperazinyl)acetyl]amino]phenyl]amino]phenylmethylene]-2-oxo-,methyl ester,(3Z)-;BIBF 1120;Nintedanib;Vargatef;Ofev;Methyl (Z)-3-[[[4-[N-methyl-2-(4-methylpiperazin-1-yl)acetamido]phenyl]amino](phenyl)methylene]-2-oxoindoline-6-carboxylate;Methyl (Z)-3-[[[4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate;928326-83-4 |
656247-17-5 | Inquiry | |
NXL 104 |
Sulfuric acid,mono[(1R,2S,5R)-2-(aminocarbonyl)-7-oxo-1,6-diazabicyclo[3.2.1]oct-6-yl] ester,sodium salt (1:1);NXL 104;(2S,5R)-7-Oxo-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide monosodium salt;Avibactam sodium;1383922-24-4 |
1192491-61-4 | Inquiry | |
obeticholic acid |
(R)-4-((3R,5R,8S,9S,10R,13R,14S,17R,E)-6-ethylidene-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid;(E)-3alpha-hydroxy-6-ethylidene-7-keto-5beta-cholan-24-oic acid;Obeticholic acid D;SCHEMBL17445150;MFCD28411244;ZINC139235351;ACN-040743;DS-9964;SC-96137;Cholan-24-oic acid, 6-ethylidene-3-hydroxy-7-oxo-, |
1516887-33-4 | Inquiry | |
tofacitinib citrate |
1-Piperidinepropanenitrile,4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-,(3R,4R)-,2-hydroxy-1,2,3-propanetricarboxylate (1:1);3-Piperidinamine,1-(cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo[2,3-d]pyrimidin-4-yl-,(3R,4R)-,2-hydroxy-1,2,3-propanetricarboxylate (1:1);Tasocitinib citrate;CP 690500-10;Tofacitinib citrate;CP 690550-10;Xeljanz;Xeljanz XR |
540737-29-9 | Inquiry |
CONTACT INFORMATION
Sign In for Details